↓ Skip to main content

Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study

Overview of attention for article published in The Lancet, January 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

blogs
1 blog
policy
3 policy sources
twitter
26 X users
patent
5 patents
facebook
2 Facebook pages
wikipedia
1 Wikipedia page

Readers on

mendeley
131 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study
Published in
The Lancet, January 2012
DOI 10.1016/s0140-6736(11)61713-3
Pubmed ID
Authors

María Elena Santolaya, Miguel L O'Ryan, María Teresa Valenzuela, Valeria Prado, Rodrigo Vergara, Alma Muñoz, Daniela Toneatto, Gabriela Graña, Huajun Wang, Ralf Clemens, Peter M Dull, for the V72P10 Meningococcal B Adolescent Vaccine Study group

Abstract

Effective glycoconjugate vaccines against Neisseria meningitidis serogroups A, C, W-135, and Y have been developed, but serogroup B remains a major cause of severe invasive disease in infants and adolescents worldwide. We assessed immunogenicity and tolerability of a four-component vaccine (4CMenB) in adolescents.

X Demographics

X Demographics

The data shown below were collected from the profiles of 26 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 131 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 2%
Ireland 1 <1%
Netherlands 1 <1%
United Kingdom 1 <1%
Kenya 1 <1%
Unknown 125 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 23 18%
Student > Master 20 15%
Student > Ph. D. Student 19 15%
Student > Bachelor 14 11%
Student > Postgraduate 12 9%
Other 22 17%
Unknown 21 16%
Readers by discipline Count As %
Medicine and Dentistry 52 40%
Agricultural and Biological Sciences 20 15%
Biochemistry, Genetics and Molecular Biology 8 6%
Immunology and Microbiology 8 6%
Nursing and Health Professions 2 2%
Other 15 11%
Unknown 26 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 45. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 February 2023.
All research outputs
#925,168
of 25,374,647 outputs
Outputs from The Lancet
#7,300
of 42,669 outputs
Outputs of similar age
#5,548
of 251,545 outputs
Outputs of similar age from The Lancet
#61
of 483 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 42,669 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 67.9. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 251,545 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 483 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.